Sort   by:  
 Page size 
UnknownUtilizing multiple in silico analyses to identify putative causal SCN5A variants in Brugada syndrome.
Not available
S-EPMC3902491 | biostudies-literature
UnknownGSTM3 variant is a novel genetic modifier in Brugada syndrome, a disease with risk of sudden cardiac death.
Not available
S-EPMC7341360 | biostudies-literature
UnknownValidation and Disease Risk Assessment of Previously Reported Genome-Wide Genetic Variants Associated With Brugada Syndrome: SADS-TW BrS Registry.
Not available
S-EPMC7439932 | biostudies-literature
UnknownClinical impact of pharmacogenetic risk variants in a large chinese cohort.
Not available
S-EPMC12241563 | biostudies-literature
UnknownComprehensive Introduction to ASIAN-HF Registry.
Not available
S-EPMC12426648 | biostudies-literature
UnknownRobust estimation of bacterial cell count from optical density.
Not available
S-EPMC7499192 | biostudies-literature
UnknownGuidelines for the use and interpretation of assays for monitoring autophagy (3rd edition).
Not available
S-EPMC4835977 | biostudies-literature
UnknownTelmisartan to prevent recurrent stroke and cardiovascular events.
Not available
S-EPMC2714258 | biostudies-literature
UnknownAspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke.
Not available
S-EPMC2714259 | biostudies-literature
UnknownThe Canagliflozin and Renal Endpoints in Diabetes with Established Nephropathy Clinical Evaluation (CREDENCE) Study Rationale, Design, and Baseline Characteristics.
Not available
S-EPMC5804835 | biostudies-literature
Sort   by:  
 Page size